Asia Pacific Medical Foods Market

Asia Pacific Medical Foods by Route of Administration (Oral, Enteral), by Product Type (Pills, Powders), by Application, by Sales Channel and by Country - Forecast 2022-2032

Analysis of Asia Pacific Medical Foods market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Asia Pacific Medical Foods Industry Outlook (2022-2032)

The Asia Pacific medical foods market size was valued at US$ 5.5 Billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% to reach US$ 11 Billion by 2032 end. The Asia Pacific (APAC) market is fairly untapped and rapid urbanization and development in the region have widened the medical foods industry.

The growing geriatric population and diseases associated with old age are key factors contributing to the growth. Lifestyle diseases associated with a sedentary lifestyle that comes with modernization and urbanization are on the rise in the region.

Report Attributes Details

Anticipated Base Year Value (2021)

US$ 5.5 Billion

Expected Market Value (2022)

US$ 5.86 Billion

Projected Forecast Value (2032)

US$ 11 Billion

APAC Growth Rate (2022-2032)

6.5% CAGR

Key Companies Profiled

  • Mead Johnson
  • SHS International Ltd.
  • Synutra International Ltd.
  • Milupa Gmbh
  • Danone
  • Nestlé
  • Abbott
  • Fresenius Kabi AG
  • GlaxoSmithKline PLC

Awareness about leading a healthy lifestyle is a key factor for the increased adoption of medical foods as preventative measures to reduce symptoms of diseases and certain diseases altogether.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

What are the Key Factors Propelling the Asia Pacific Medical Foods Market Growth?

According to the United Nations Population Fund (UNFPA), by 2050 Asia Pacific will have one in four people aged above 60. The geriatric population will be nearly 1.3 billion. With the increase in the geriatric population, health issues arising due to the same have also been on the rise. Lifestyle diseases associated with aging are also key factors contributing to the growth of the market.

Asia Pacific region where urbanization and development have increased the overall life expectancy but have also caused a shift in causes of mortality from communicable diseases to non-communicable diseases. The leading factor for mortality is cardiovascular diseases and cancer. According to the OECD data, cancer caused nearly 4.5 million deaths in the APAC region.

The increase in overall awareness around medical food has driven the market growth significantly in recent years. The markets in China and South Korea are seeing massive uptake of medical foods and the demand for the same is steadily rising.

Instead of this, the countries are speeding up processes for more imports and also investing in their portfolios to expand in the regional market. The market for medical foods for specific rare diseases is gaining momentum and being prioritized for registration by the governments.

The rapid urbanization and high burden of the diseases coupled with the massive impact that the pandemic had on the health of people have increased the uptake of medical foods. This in turn has resulted in the growth of the industry.

What are the Major Trends in the Global Asia Pacific Medical Foods Market?

China’s snowballing interest in Nicotinamide mononucleotide (NMN), colloquially known as the ‘longevity pill” in the country, has pushed sales to a new high for the brands from US brand doctor’s Best, New Zealand’s EZZ, and Japan’s NADaltus.

According to the China Chamber of Commerce for Import and Export Medicines and Health products (CCCMPHIE), the influx of NMN products from the US had boosted the country’s overall exports of neurochemicals into China this year.

On the other hand, Swisse launched a halal-certain multivitamin in Singapore and Malaysia and is planning to launch more of such products in the region. the company currently has two halal-certified products, namely Swisse Ultivite E-Sentinel Multivitamin and Swisse Ultibiotic Daily Balance Probiotic, after obtaining halal certification from the Halal Certification Authority Australia (HCAA).

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

What Challenges are in Store for Filter Asia Pacific Medical Foods Sales?

Despite several benefits and advantages, these medical foods present a few challenges in front of consumers and manufacturers which is likely to hinder their market growth.

Some of them include, the lack of knowledge of the appropriate usage of medical food, the relatively expensive cost of medical food relative to conventional food items, and the inferior supply of medical food in established countries are expected to hamper the development of the global medical foods market in the coming years.

Along with this, the oral route of administration may cause some insignificant hindrance in its usage. The factors causing the contamination of the food may threaten the safe consumption of these medical products and thereby make the foods harmful to human & health.

Asia pacific medical foods market forecast by Fact.MR

Segment-wise Analysis

Which Route of Administration the Segmental Analysis for the Global Asia Pacific Medical Foods Market?

The oral route of administration segment held a staggering market share of 69% in the region. The growth can be attributed to the wider product range in this segment. Major players in the medical food industry have product portfolios catering to the demand for the oral route of administration, which is a key factor driving this market. The oral route has been the most preferred format for the administration of medical foods, due to its ease and wider acceptance.

The enteral feeding segment, on the other hand, is expected to witness the fastest CAGR in the forecast period. This growth of the segment can be due to the rise in the geriatric population and diseases afflicting them. Some chronic conditions render the oral route of administration impossible or futile, thus enteral feeding becomes the choice for better nutrition management in patients with special needs.

Which Product Type Segment is expected to lead the Global Asia Pacific Medical Foods Market?

The powder segment held the largest market share of 35.4% in 2021. Higher product availability and longer shelf-life of this type of product have brought about the growth of this segment. Product portfolios of all the major players in the industry mainly consist of powder formulations and are a key factor for a large revenue share.

The liquid product type is expected to register the fastest CAGR in the forecast period. Expansion of product portfolios by medical food players is a key factor contributing to the rapid growth of this segment. The ease of use of liquid formulations for infants and adults alike is also a key factor contributing to the growth of the segment.

Which Application of Asia Pacific Medical Foods is Gaining Highest Traction?

Chemotherapy-induced diarrhoea held the largest market share of 15.2% in 2021. As per the data obtained by the WHO, cancer caused nearly 4.5 million deaths in a year in the region. Consumers and patients are becoming more aware of the need to manage disease symptoms and side effects; this has been a key factor driving growth. Clinicians and doctors are more open to non-traditional methods and medically nutritive foods for nutritional supplementation.

Diabetic neuropathy is expected to emerge as the fastest-growing segment over the forecast period. Diabetes, as a lifestyle disease, has seen an overall increase in recent years, especially with the urbanization and fast development in the region, its prevalence has increased. Diabetes and its associated symptoms can be managed with proper nutrition, this is the key factor contributing to the rapid growth of this segment.

Country-wise Insights

Which country accounts for more enhanced demand for Asia Pacific Medical Foods Market?

China had the largest market share of 20.8% in 2021. The increase in awareness in the Chinese population regarding the health benefits and the use of medical foods in mitigating and managing diseases and their symptoms has grown in recent years. The public has been more welcoming to medical foods for completing nutritional requirements for the elderly and patients with cancer.

India is anticipated to register the fastest CAGR over the forecast period, owing to the rapidly growing population, rising geriatric & infant populations, and increasing disease prevalence. Rising awareness about medical foods and their benefits in managing symptoms of diseases has been the primary factor for the growth of this region.

The demand for health products in Japan is proliferating at a Y-o-Y rate of 6.2% and is expected to reach US$ 1.8 Billion by the end of the forecast period.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Competitive Landscape

Prominent Asia Pacific Medical Foods providers are reliant on partnerships, collaborations, acquisitions, and new software launches to stay afloat in the global market. Constant innovations to ensure a seamless client-customer relationship are the main focus of prominent market players.

Fact.MR has provided detailed information about the price points of key manufacturers in the Asia Pacific Medical Foods market positioned across countries, sales growth, production capacity, and speculative technological expansion in the recently published report.

  • In June 2021, Primavera Capital Group ("Primavera") announced that it has signed a definitive agreement with Reckitt Benckiser Group plc, a world's leading consumer health, nutrition, and hygiene company, to acquire the Greater China business of the Mead Johnson Nutrition Company, a global leading infant formula, and Nutrition Company owned by Reckitt.
  • In May 2022, Nestle Health Science, a business unit of Nestle SA, has agreed to acquire Puravida, a Brazilian nutrition and lifestyle brand that manufactures and markets such applications as drink mixes, and protein powders, nutrition bars, and snacks that are based in São Paulo. The terms of the agreement were not disclosed.

Key Segments Covered in the Asia Pacific Medical Foods Industry Survey

  • Asia Pacific Medical Foods Market by Route of Administration :

    • Oral Medical Foods
    • Enteral Medical Foods
  • Asia Pacific Medical Foods Market by Product Type :

    • Medical Food Pills
    • Medical Food Powders
    • Other Medical Food Product Types
  • Asia Pacific Medical Foods Market by Application :

    • Chronic Kidney Disease
    • Minimal Hepatic Encephalopathy
    • Chemotherapy-Induced Diarrhea
    • Pathogen Related Infections
    • Diabetic Neuropathy
    • ADHD
    • Depression
    • Alzheimer's disease
    • Nutritional Deficiency
    • Orphan Diseases
      • Phenylketonuria
      • Eosinophilic Esophagitis
      • FRIESES
      • Others
    • Wound Healing
    • Chronic Diarrhea
    • Constipation Relief
    • Protein Booster
    • Dysphagia
    • Other Diseases
      • Parkinson’s Disease
      • Epilepsy
      • Pain Management
      • Other Cancer Related Treatments
  • Asia Pacific Medical Foods Market by Sales Channel :

    • Online Sales
    • Retail Sales
    • Institutional Sales
  • Asia Pacific Medical Foods Market by Country :

    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Singapore
    • South Korea

- FAQs -

What is the expected worth of the Asia Pacific Medical Foods industry in 2022?

By 2022, Fact.MR expected demand for Asia Pacific Medical Foods to reach US$ 5.8 Billion.

What is the expected forecast CAGR for Asia Pacific Medical Foods from 2022 to 2032?

From 2022-to 2032, Asia Pacific Medical Foods demand is likely to surge at a 6.5% CAGR.

What are the expected growth rates for the South Korean and Japanese markets?

South Korea and Japan are expected to document CAGRs worth 6.5% and 6.2% respectively in the Asia Pacific Medical Foods market.

At what rate did the Asia Pacific Medical Foods market flourish from 2015-to 2021?

From 2015-to 2021, the Asia Pacific Medical Foods market grew at a ~6% value CAGR.

At what value will the market for Asia Pacific Medical Foods close in 2032?

By 2032, the market for Asia Pacific Medical Foods is likely to be valued at US$ 11 Billion.

Which product type will account for the maximum Asia Pacific Medical Foods revenue?

The demand for the powdered segment will be maximum, expanding at a 6.7% CAGR.

By route of administration, which category is likely to remain top-selling until 2032?

The oral segment will remain most preferred, expanding at a CAGR of 6.6% until 2032.

What was the market worth for Asia Pacific Medical Foods in 2021?

As of 2021, Fact.MR estimated the Asia Pacific Medical Foods market to have reached US$ 5.5 Billion.

Asia Pacific Medical Foods Market